Quest Diagnostics
824 hedge funds and large institutions have $13.7B invested in Quest Diagnostics in 2023 Q4 according to their latest regulatory filings, with 108 funds opening new positions, 253 increasing their positions, 328 reducing their positions, and 64 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
824
Holders Change
+32
Holders Change %
+4.04%
% of All Funds
12.08%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.03%
New
108
Increased
253
Reduced
328
Closed
64
Calls
$176M
Puts
$78.3M
Net Calls
+$97.7M
Net Calls Change
+$5.2M
Top Buyers
| 1 |
Morgan Stanley
New York
|
+$289M |
| 2 |
DSA
Davis Selected Advisers
Tucson,
Arizona
|
+$138M |
| 3 |
NI
Nuance Investments
Kansas City,
Missouri
|
+$83.1M |
| 4 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$54.7M |
| 5 |
Alyeska Investment Group
Chicago,
Illinois
|
+$51.7M |
Top Sellers
| 1 |
BlackRock
New York
|
-$111M |
| 2 |
LSV Asset Management
Chicago,
Illinois
|
-$83.5M |
| 3 |
Pictet Asset Management
Carouge,
Switzerland
|
-$56.4M |
| 4 |
Nordea Investment Management
Stockholm,
Sweden
|
-$53.2M |
| 5 |
UBS AM
Chicago,
Illinois
|
-$35.8M |
